Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1832 to 1881 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1832\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 7 (ec 2.7.1.-) (map kinase kinase 7) (mapkk 7) (mapk/erk kinase 7) (jnk activating kinase 2) (c-jun n-terminal kinase kinase 2) (jnk kinase 2) (jnkk 2). [source:swissprot;acc:o14733]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-formyltetrahydrofolate cyclo-ligase (ec 6.3.3.2) (5,10-methenyl- tetrahydrofolate synthetase) (methenyl-thf synthetase) (mthfs). [source:swissprot;acc:p49914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6175.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6572.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3593.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3375.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 2 (transcription elongation factor s-ii protein 2) (testis-specific s-ii) (transcription elongation factor tfiis.l). [source:swissprot;acc:q15560]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5019.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5342.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06436\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o). [source:swissprot;acc:p23193]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5739.49\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6108.72\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06433\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1838\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 70 kda subunit (lupus ku autoantigen protein p70) (ku70) (70 kda subunit of ku antigen) (thyroid-lupus autoantigen) (tlaa) (ctc box binding factor 75 kda subunit) (ctcbf) (ctc75). [source:swissprot;acc:p12956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 80 kda subunit (lupus ku autoantigen protein p86) (ku86) (ku80) (86 kda subunit of ku antigen) (thyroid- lupus autoantigen) (tlaa) (ctc box binding factor 85 kda subunit) (ctcbf) (ctc85) (nuclear factor iv) (dna-repair protein xrcc5). [source:swissprot;acc:p13010]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3591.95\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3375.34\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06417\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ligatin (hepatocellular carcinoma-associated antigen 56). [source:swissprot;acc:p41214]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6215.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6613.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-alpha (hsp 86). [source:swissprot;acc:p07900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5746.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6113.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6267.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6668.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1850\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c binding protein 1 (rack7) (cutaneous t-cell lymphoma associated antigen se14-3) (ctcl tumor antigen se14-3) (zinc finger mynd domain containing protein 8). [source:swissprot;acc:q9ulu4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6158.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6551.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenovirus 5 e1a-binding protein (bs69 protein). [source:swissprot;acc:q15326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6156.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6549.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0638\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginase 1 (ec 3.5.3.1) (liver-type arginase). [source:swissprot;acc:p05089]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6271.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6670.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9.2. [source:refseq;acc:nm\_031961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&\multirow{19}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\multirow{27}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.15\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1859\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.9 (fragment). [source:sptrembl;acc:q9byq8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1860\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-12; keratin associated protein 4.12. [source:refseq;acc:nm\_031854]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 1.5. [source:refseq;acc:nm\_031957]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein b (uhs keratin b) (uhs kerb). [source:swissprot;acc:o75690]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein a (uhs keratin a) (uhs kera). [source:swissprot;acc:p26371]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 5 (stard5) (start domain- containing protein 5). [source:swissprot;acc:q9nsy2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.4. [source:refseq;acc:nm\_032524]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integrin-linked protein kinase 1 (ec 2.7.1.-) (ilk-1) (59 kda serine/threonine protein kinase) (p59ilk). [source:swissprot;acc:q13418]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 4 (stard4) (start domain- containing protein 4). [source:swissprot;acc:q96dr4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras suppressor protein 1 (rsu-1) (rsp-1). [source:swissprot;acc:q15404]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 1 (gap sh3-domain binding protein 1) (g3bp-1). [source:swissprot;acc:q13283]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s11. [source:swissprot;acc:p04643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3618.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3402.09\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 2 (gap sh3-domain binding protein 2) (g3bp-2). [source:swissprot;acc:q9un86]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 1-3; keratin associated protein 1.3. [source:refseq;acc:nm\_030966]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
espin. [source:refseq;acc:nm\_031475]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 2d6 (ec 1.14.14.1) (cypiid6) (p450-db1) (debrisoquine 4-hydroxylase). [source:swissprot;acc:p10635]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim and senescent cell antigen-like domains 2; ilk-binding protein. [source:refseq;acc:nm\_017980]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
d(4) dopamine receptor (d(2c) dopamine receptor). [source:swissprot;acc:p21917]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9-4; keratin associated protein 9.4. [source:refseq;acc:nm\_033191]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6462.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0635\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/